1 / 6

Hepatitis Drugs Market

Hepatitis is a viral infection that affects the liver and can lead to inflammation, liver damage, and other complications. There are several types of hepatitis viruses, including hepatitis A, B, C, D, and E. The treatment of hepatitis depends on the specific virus causing the infection.

Aarav658
Télécharger la présentation

Hepatitis Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Hepatitis Drugs Market Market Size (2023) US$ 21,148.3 MN CAGR (2023–2030) 3.2% Market Size (2030) US$ 27,180.1BN

  2. Segmentation (Scope) By Disease By Drugs Class • Hepatitis B • Interferon Alphas • Hepatitis C • HIV NRTIs • Nucleotide Polymerase / • NS5A Inhibitor Combinations • Others • Hepatitis C Protease / • NS5A Inhibitor Combinations • NS5A Inhibitors • Nucleotide Polymerase Inhibitors • Nucleoside Analogue Antivirals • Thrombopoiesis Stimulating Agents © Coherent Market Insights. All Rights Reserved

  3. Key Facts • Direct-acting antiviral (DAA) therapies have transformed the treatment of hepatitis C virus (HCV) infections. • DAAs offer high cure rates and fewer side effects compared to older treatment options. • The rising prevalence of hepatitis infections worldwide is driving the growth of the hepatitis drugs market. • The development of vaccines for hepatitis B virus (HBV) and innovative therapies for hepatitis D virus (HDV) is an area of focus in the market. © Coherent Market Insights. All Rights Reserved

  4. Market Purview • The market includes a range of medications, including antiviral drugs, immunomodulators, and combination therapies. • Hepatitis drugs aim to reduce viral replication, suppress the virus, and prevent liver damage or cirrhosis. • The market is driven by factors such as the increasing prevalence of hepatitis infections globally, growing awareness about the availability of effective treatments, and advancements in drug development. © Coherent Market Insights. All Rights Reserved

  5. Few Leading Companies Merck & Co. Inc. Gilead Sciences Inc. AbbVie Inc. Bristol Myers Squibb Company © Coherent Market Insights. All Rights Reserved

More Related